Rare diseases
Investigational molecules
Locations
5980 Horton Street Ste 550, 94608-2045, United States
Kyverna Therapeutics Inc. focuses on generalized myasthenia gravis, myasthenia gravis, and stiff person syndrome, with clinical interest centered on immune-mediated weakness, neuromuscular transmission disorders, and related autoimmune disease mechanisms.
The sponsor also studies CD19-directed cell therapy approaches in these conditions, reflecting a therapeutic emphasis on refractory neuromuscular autoimmunity.
Kyverna Therapeutics Inc. runs clinical trials in conditions such as Myasthenia gravis, Systemic scleroderma, Lupus nephritis, Rheumatoid arthritis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyGermany
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
